Effects of prednisone on biomarkers of tubular damage induced by radiocontrast in interventional cardiology

Journal of Nephrology

Volumn 26, Issue 3, 2013, Pages 586-593

  Ribichini, Flavio ^a   Gambaro, Alessia ^a   Pighi, Michele ^a   Pesarini, Gabriele ^a   Ferraro, Pietro Manuel ^b   Zuppi, Cecilia ^b   Baroni, Silvia ^b   Penitente, Romina ^b   Ferrero, Valeria ^a   Vassanelli, Corrado ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Acute kidney injury; Contrast induced nephropathy; Interventional cardiology; KIM 1; NGAL; Steroids

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IODIXANOL; IOHEXOL; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PREDNISONE; PROTEIN; THIENOPYRIDINE DERIVATIVE;

AGED; ALBUMINURIA; ARTICLE; CLINICAL ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MEGADOSE; FEMALE; HUMAN; HYDRATION; HYPERTENSION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; KIDNEY TUBULE DAMAGE; LOW DRUG DOSE; MALE; PERIPHERAL VASCULAR DISEASE; PILOT STUDY; PREDICTION; PROTEIN URINE LEVEL; PROTEINURIA; RENAL PROTECTION;

AGED; ANGIOGRAPHY; BIOLOGICAL MARKERS; CARDIAC IMAGING TECHNIQUES; CONTRAST MEDIA; FEMALE; GLUCOCORTICOIDS; HUMANS; KIDNEY DISEASES; KIDNEY TUBULES; MALE; PILOT PROJECTS; PREDNISONE;

EID: 84877969009     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000266     Document Type: Article

References (34)

1. Barrett BJ, Parfrey PS, Vavasour HM, et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int. 1992;41(5):1274-1279.
2. Murakami R, Tajima H, Kumazaki T, Yamamoto K. Effect of iodixanol on renal function immediately after abdominal angiography: clinical comparison with iomeprol and ioxaglate. Acta Radiol. 1998;39(4):368-371.
3. Morabito S, Pistolesi V, Benedetti G, et al. Incidence of contrast-induced acute kidney injury associated with diagnostic or interventional coronary angiography. J Nephrol. 2012;25(6):1098-1107.
4. Ribichini F, Graziani M, Gambaro G, et al. Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. Am J Med. 2010;123(8): 755-763.
5. Ribichini F, Gambaro G, Graziani MS, et al. Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. Clin Chem. 2012;58(2):458-464.
6. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930-936.
7. Stratta P, Bozzola C, Quaglia M. Pitfall in nephrology: contrast nephropathy has to be differentiated from renal damage due to atheroembolic disease. J Nephrol. 2012;25(3):282-289.
8. Saklayen MG, Gupta S, Suryaprasad A, Azmeh W, Saklayen MG. Incidence of atheroembolic renal failure after coronary angiography: a prospective study. Angiology. 1997;48(7): 609-613.
9. Fukumoto Y, Tsutsui H, Tsuchihashi M, Masumoto A, Takeshita A. Cholesterol Embolism Study (CHEST) Investigators. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol. 2003;42(2): 211-216.
10. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105(19):2259-2264.
11. Iakovou I, Dangas G, Mehran R, et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol. 2003;15(1):18-22.
12. Pighi M, Pasoli P, Pesarini G, Mugnolo A, Bolzan B, Ribichini F, Vassanelli C. Long-term prognosis of contrast-induced nephropathy: a prospective study with 3 years follow-up [abstract]. Eur Heart J. 2012;32(Abstract Suppl):76.
13. Ishani A, Nelson D, Clothier B, et al. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med. 2011;171(3):226-233.
14. Scolari F, Ravani P. Atheroembolic renal disease. Lancet. 2010;375(9726):1650-1660.
15. Rudnick MR, Goldfarb S. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. Rev Cardiovasc Med. 2003;4(Suppl 5):S28-S33.
16. Andreucci M, Lucisano G, Faga T, et al. Differential activation of signaling pathways involved in cell death, survival and inflammation by radiocontrast media in human renal proximal tubular cells. Toxicol Sci. 2011;119(2):408-416.
17. Heinrich MC, Kuhlmann MK, Grgic A, Heckmann M, Kramann B, Uder M. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro. Radiology. 2005;235(3):84384-84389.
18. Lee HC, Chang JG, Yen HW, Liu IH, Lai WT, Sheu SH. Ionic contrast media induced more apoptosis in diabetic kidney than nonionic contrast media. J Nephrol. 2011;24(3):376-380.
19. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162(3):329-336.
20. Wijns W, Kolh P, Danchin N, et al. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI). Guidelines on myocardial revascularization. Eur Heart J. 2010;31(20):2501-2555.
21. Belenfant X, Meyrier A, Jacquot C. Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis. 1999;33(5):840-850.
22. Stabellini N, Cerretani D, Russo G, Rizzioli E, Gilli P. [Renal atheroembolic disease: evaluation of the efficacy of corticosteroid therapy] [article in Italian]. G Ital Nefrol. 2002;19(1): 18-21.
23. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2)(Suppl 1): S1-S266.
24. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.
25. Waring WS, Moonie A. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury. Clin Toxicol. 2011;49(8):720-728.
26. Kumar S, Allen DA, Kieswich JE, et al. Dexamethasone ameliorates renal ischemia-reperfusion injury. J Am Soc Nephrol. 2009;20(11):2412-2425.
27. Lipworth BJ. Therapeutic implications of non-genomic glucocorticoid activity. Lancet. 2000;356(9224):87-89.
28. Buttgereit F, da Silva JAP, Boers M, et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis. 2002;61(8):718-722.
29. Pesarini G, Amoruso A, Ferrero V, et al. Cytokines release inhibition from activated monocytes, and reduction of instent neointimal growth in humans. Atherosclerosis. 2010; 211(1):242-248.
30. Hirsch R, Dent C, Pfriem H, et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol. 2007;22(12):2089-2095.
31. Malyszko J, Bachorzewska-Gajewska H, Poniatowski B, Malyszko JS, Dobrzycki S. Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. Ren Fail. 2009;31(10):910-919.
32. Han WK, Waikar SS, Johnson A, et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008;73(7):863-869.
33. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute Dialysis Quality Initiative workgroup. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs. The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4): R204-R212.
34. Pappy R, Stavrakis S, Hennebry TA, Abu-Fadel MS. Effect of statin therapy on contrast-induced nephropathy after coronary angiography: a meta-analysis. Int J Cardiol. 2011;151(3): 345-353.